Nordic Pancreatic Cancer Trial (NorPACT) - 1

Study ID
NCT02919787

Study type
Interventional

Study phase
Phase 2/Phase 3

Study status
Active, not recruiting

Trial Acronym

Trial Summary

This study evaluate the additional effect of adding chemotherapy prior to resection of a pancreatic head malignancy. The patients will be randomized into two groups; surgery first (control group) and neoadjuvant chemotherapy (intervention). Primary endpoint is overall survival after resection

More informations

Trial Starting Date

Sep 30,2016

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

140